Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol Contrast for MRI in Osteomyelitis
NCT05959590Phase 1Completed
- Sponsor
- The University of New Mexico
- Start
- Feb 2014
- Primary completion
- Aug 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ferumoxytol in osteomyelitis (OM), sponsored by The University of New Mexico. Primary endpoint: Contrast changes at 6 weeks. Started Feb 2014; status: completed.
02
Drugs
ferumoxytol
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on NCT05959590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05959590.